# Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB

> **NCT01072838** · PHASE2 · TERMINATED · sponsor: **SenoRx, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** APBI (Dose Escalation)
- **DEVICE:** Contura MLB Breast Brachytherapy Catheter

## Key facts

- **NCT ID:** NCT01072838
- **Lead sponsor:** SenoRx, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01072838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01072838, "Safety Study for Short-course Accelerated, Hypofractionated Partial Breast Radiotherapy (APBI) in Women With Early Stage Breast Cancer Using the Contura MLB". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01072838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*